Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Spirit Airlines Reaches Agreements with Pilots and Flight Attendants as it Continues to Advance its Restructuring
-
Nurix Therapeutics Presents New Translational Data from First-in-Human Clinical Trial of Oral CBL-B Inhibitor NX-1607 Demonstrating Immune Activation and Tumor Microenvironment Remodeling
-
Unwrap a Magical Holiday Escape at Four Seasons Resort Orlando at Walt Disney World Resort
-
Ivonescimab Plus Chemotherapy Demonstrates a Statistically Significant Benefit in Overall Survival with a Hazard Ratio of 0.74 in 2L+ Treatment of Patients with EGFRm NSCLC in HARMONi-A Study Conducte
-
Indapta Therapeutics Presents Data Demonstrating Clinical Activity of its Allogeneic Natural Killer Cell Therapy in Patients with Relapsed/Refractory Multiple Myeloma
-
Kapitale Secures $25M Credit Facility to Empower US Small Businesses
-
James Hardie Announces Participation At Upcoming Investor Conferences and Timing of Second Quarter FY26 Earnings Release & Conference Call
-
Malar Group Announces Strategic Investment In Spendsafe To Transform Financial Literacy For The Next Generation
-
Nexteer Expands India Technical Center to Advance Driveline Validation Capabilities
-
Dragon Shield & Beckett Send First Sleeved TCG Card To the Edge of Space
-
Stewart Strengthens Real Estate Services Portfolio by Announcing its Intent to Acquire Mortgage Contracting Services (MCS)
-
Experian Named a Leader in IDC MarketScape: Worldwide Identity Verification in Financial Services 2025 Vendor Assessment
-
Gold Prices Continue to Fluctuate at High Levels, Blue Hat's Gold Assets Deliver Significant Returns
-
Intapp DealCloud named Deal Origination Solution of the Year: Credit at the 2025 Private Equity Wire U.S. Awards
-
Knight-Swift Transportation Holdings Inc. Announces Quarterly Cash Dividend
-
Diakonos Oncology Presents Promising Preliminary Data from Phase 1 Study of DOC1021 Cell-Based Immunotherapy in Pancreatic Cancer at Society for Immunotherapy of Cancer 40th Annual Meeting
-
BioAtla’s Mecbotamab Vedotin (Mec-V), an AXL-targeting ADC, Demonstrates a Median Overall Survival (OS) of 21.5 months in Subtypes of Refractory Soft Tissue Sarcomas
-
Taxbit Wins the Digital Banker’s 2025 Digital Assets Award for Best Technology Solution Provider for Digital Assets - Tax & Compliance Automation
-
CoreTrust Partners with NPI to Launch Exclusive Solution for Smarter IT Spend Management
-
Maneesh K. Goyal Appointed President and Executive Chairman of Interluxe Group
-
Statistically significant NATRON Phase III trial results for hypereosinophilic syndrome show FASENRA delayed time to first flare or worsening of disease
-
Anchoring the 15th Five-Year Plan: China's High-quality Development is Strengthening Foreign Investors' Confidence
-
Webull Becomes Young Investors Society Sponsor, Furthering Mission to Empower Financial Education Amongst Youth
-
Synthekine Presents Positive Initial Results from Phase 1a/1b Clinical Trial of STK-012 Plus Pembrolizumab and Chemotherapy in First-Line, PD-L1 Negative Nonsquamous Non-Small Cell Lung Cancer
-
Wrap and LETAC Lead Policy Development for Human Centered Non-Lethal Integration of Humanoid Robotics in Public Safety
-
CREATE Medicines Announces Positive First-in-Human Results for MT-302
-
Westfield Specialty achieves 89.9% CR in Q3 as GWP reaches $1.4bn for the year
-
Wienerschnitzel Honors Veterans and Active-Duty Military with Free Meal on Veterans Day
-
Merit Financial Advisors Partners with Mennenga Tax & Financial, Expands Capabilities for Clients in Wisconsin
-
BioAge Labs to Present at Jefferies Global Healthcare Conference in London
-
Global Battery Materials Forms New Company to Close Ex-China Graphite Critical Mineral Supply Gap
-
Precision Optics Announces Product Development Agreement to Deliver Next-Generation Augmented Reality Sub-Systems for Fighter Pilots
-
Fastbreak AI Raises $40 Million Series A to Fuel Expansion Across Pro and Amateur Sports
-
Nouscom Presents New Positive Phase 1/2b data of NOUS-209 at SITC 2025, Supporting Plans to Initiate Registration-Enabling Study for Cancer Interception in Lynch Syndrome Carriers
-
Creative Realities Closes Acquisition of Cineplex Digital Media
-
Trump Media Reports Third Quarter 2025 Results
-
H/Advisors Abernathy Named Private Equity Wire’s U.S. PR & Communications Firm of the Year in 2025 for Second Consecutive Year
-
Flare Therapeutics Presents Correlative Biomarker Analysis from the FX-909 Phase 1A Clinical Study at SITC 2025 40th Anniversary Annual Meeting
-
Wearable Devices Expands into Asia’s Tech Powerhouse: Secures Exclusive Distribution Agreement in South Korea
-
RFN's SX-E60: A New Era of Control in Electric Off-Roading Explored at EICMA Roundtable
-
Draganfly to Host Shareholder Update Call on November 12, 2025
-
Fullmark Energy Announces Completion of Redwood Projects Portfolio with Commercial Operations of 65MW San Jacinto Energy Storage Project
-
NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1/2a Clinical Trial and Compassionate Use Program
-
Coherus Oncology Presents at SITC Clinical Multiomic Biomarker Data for CHS-114, a Highly Selective anti-CCR8 Cytolytic Antibody
-
MiNK Therapeutics Reports Durable Responses and Immune Reactivation with Allo-iNKT Cell Therapy agenT-797 in PD-1–Refractory Solid Tumors at SITC 2025
-
Legrand Acquires Avtron Power Solutions, a Global Provider of Load Banks & Power Quality Solutions
-
ETC’s Commercial/Industrial Unit Awarded Contracts Totaling $9.1 Million
-
Round Table Pizza Brings Legendary Flavor to Austin Area
-
CTS Corporation Declares a Dividend and Share Repurchase Program
-
Elicio Therapeutics Reports Robust, Cytolytic mKRAS-Specific T Cell Responses Across Diverse Patient HLA in Ongoing Phase 2 AMPLIFY-7P Trial of ELI-002 7P and New ELI-004 Preclinical Data at SITC
